Trials / Completed
CompletedNCT00469755
Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-week Treatment Switched to Tazorac® Cream, 0.1% 6-week Treatment in Patients With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 302 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of 12 weeks of treatment with Differin Gel, 0.1% compared to 12 weeks of treatment with Tazorac Cream, 0.1% and compared to 6 weeks treatment with Differin Gel, 0.1% followed by 6 weeks of treatment with Tazorac Cream
Detailed description
Same as above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adapalene Gel, 0.1% | Apply once daily in the evening for 12 weeks |
| DRUG | Tazarotene Cream, 0.1% | Apply once daily in the evening for 12 weeks |
| DRUG | Adapalene Gel, 0.1% + Tazarotene Cream, 0.1% | Apply adapalene Gel, 0.1% once daily in the evening for 6 weeks and Tazarotene Cream, 0.1% once daily in the evening for 6 weeks |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2007-05-04
- Last updated
- 2022-07-29
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00469755. Inclusion in this directory is not an endorsement.